Page last updated: 2024-10-24

chelerythrine and Vitreoretinopathy, Proliferative

chelerythrine has been researched along with Vitreoretinopathy, Proliferative in 1 studies

chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.

Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.

Research Excerpts

ExcerptRelevanceReference
"To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR)."7.73Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. ( Er, H; Mizrak, B; Parlakpinar, H; Turkoz, Y, 2006)
"To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR)."3.73Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. ( Er, H; Mizrak, B; Parlakpinar, H; Turkoz, Y, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Er, H1
Turkoz, Y1
Mizrak, B1
Parlakpinar, H1

Other Studies

1 other study available for chelerythrine and Vitreoretinopathy, Proliferative

ArticleYear
Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin.
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2006, Volume: 220, Issue:1

    Topics: Alkaloids; Animals; Benzophenanthridines; Disease Models, Animal; Disease Progression; Drug Therapy,

2006